A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
Clinical trial NCT00808210 · TERMINATED
Trial details
- NCT number
- NCT00808210
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-05
- Primary completion
- 2012-11-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.